(BPT) - This World Hypoparathyroidism Awareness Day, a global awareness and education event observed annually on June 1, the HypoPARAthyroidism Association (HPA) is calling for urgent change within the hypoPARAthyroidism
Amolyt Pharma to Host Hybrid Key Opinion Leader Event on Eneboparatide, a PTHR1 Agonist Entering Phase 3 for the Treatment of Hypoparathyroidism, in Chicago on June 16, 2023LYON, France and CAMBRIDGE, Mass., June 07, 2023 (GLOBE NEWSWIRE) Amolyt Pharma, a global company specialized in developing therapeutic pepti.
LYON, France and CAMBRIDGE, Mass., June 07, 2023 (GLOBE NEWSWIRE) Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
(BPT) - Living with chronic pain makes day-to-day life incredibly challenging. It can interfere with everyday activities such as cooking, housework, and even just running simple errands. Dealing with pain